vimarsana.com
  1. Home
  2. Live Updates
  3. Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts : vimarsana.com

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts

theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Raymond James ,Maha Katabi ,Barclays Plc ,Capital Partners ,Vera Therapeutics Company Profile ,Goldman Sachs Group Inc ,Nasdaq ,Vanguard Group Inc ,Vera Therapeutics Inc ,Cantor Fitzgerald ,Vera Therapeutics ,Get Free Report ,Therapeutics Trading Down ,Director Maha Katabi ,Sachs Group ,Get Free ,Vera Therapeutics Daily ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.